MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 5.37
+0.07 (1.32%)
Apr 24, 2026, 12:33 PM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €99.87 million as of April 24, 2026. Its market cap has increased by 5.53% in one year.
Market Cap
99.87M
Enterprise Value
92.44M
Revenue
4.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.37
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 99.87M, a decrease of -24.76%. That is a compound annual growth rate of -6.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 99.87M | 28.92% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 241.73M |
| Transgene | 206.51M |
| Sensorion | 197.40M |
| ABIONYX Pharma | 128.76M |
| Innate Pharma | 108.28M |
| Adocia | 92.48M |
| Valerio Therapeutics Société anonyme | 73.82M |
| OSE Immunotherapeutics | 68.92M |